Comparative pharmacological profiles of morphine and oxycodone under a neuropathic pain-like state in mice: Evidence for less sensitivity to morphine

Neuropsychopharmacology

Volumn 33, Issue 5, 2008, Pages 1097-1112

  Narita, Minoru ^a   Nakamura, Atsushi ^a   Ozaki, Masahiko ^a   Imai, Satoshi ^a   Miyoshi, Kan ^a   Suzuki, Masami ^a   Suzuki, Tsutomu ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Antinociception; M 6 G; Morphine; Neuropathic pain; Oxycodone; Rewarding effect

Indexed keywords

3,4 DICHLORO N METHYL N [1 PHENYL 2 (1 PYRROLIDINYL)ETHYL]BENZENEACETAMIDE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; BETA FUNALTREXAMINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MORPHINE; MORPHINE 6 GLUCURONIDE; MU OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; OXYCODONE; SULFUR 35;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GUINEA PIG; HYPERALGESIA; MALE; MESENCEPHALON; MOUSE; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; SCIATIC NERVE; SHAM PROCEDURE; SPINAL CORD; THALAMUS; THERMAL STIMULATION;

ANIMALS; CENTRAL NERVOUS SYSTEM; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; DRUG INTERACTIONS; FREUND'S ADJUVANT; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); INFLAMMATION; MALE; MICE; MICE, INBRED ICR; MORPHINE; MORPHINE DEPENDENCE; NARCOTIC ANTAGONISTS; NARCOTICS; OXYCODONE; PAIN MEASUREMENT; PROTEIN BINDING; SCIATICA; SULFUR ISOTOPES;

EID: 40549115667     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301471     Document Type: Article

References (44)

1. Bostrom E, Simonsson US, Hammarlund-Udenaes M (2006). In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics/ pharmacodynamics. Drug Metab Dispos 34: 1624-1631.
2. Funada M, Suauki T, Misawa M (1995). Role of mesolimbic dopamine system in morphine dependence. Ann Psychiatry 5: 222-237.
3. Garzon M, Pickel VM (2001). Plasmalemmal m-opioid receptor distribution mainly in nondopaminergic neurons in the rat ventral tegmental area. Synapse 41: 311-328.
4. Haley MJ, McCormick WG (1957). Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br J Pharmacol 12: 12-15.
5. Hao JX, Yu W, Wiesenfeld-Hallin Z, Xu XJ (1998). Treatment of chronic allodynia in spinally injured rats: effects of intrathecal selective opioid receptor agonists. Pain 75: 209-217.
6. Heiskanen T, Kalso E (1997). Controlled-release oxycodone and morphine in cancer related pain. Pain 73: 37-45.
7. Hylden JLK, Wilcox GL (1980). Intrathecal morphine in mice: a new technique. Eur J Pharmcol 67: 313-316.
8. Kilpatrick GJ, Smith YW (2005). Morphine-6-glucuronide: actions and mechanisms. Med Res Rev 25: 521-544.
9. Krames E (2002). Implantable devices for pain control: spinal cord stimulation and intrathecal therapies. Best Pract Res Clin Anaesthesiol 16: 619-649.
10. Le Bars D, Gozriu M, Cadden SW (2001). Animal models of nociception. Pharmacol Rev 53: 597-652.
11. Lee YW, Chaplan SR, Yaksh TL (1995). Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model. Neurosci Lett 199: 111-114.
12. Lemberg K, Kontinen VK, Viljakka K, Kylanlahti I, Yli-Kauhaluoma J, Kalso E (2006b). Morphine, oxycodone, methadone and its enantiomers in different models of nociception in the rat. Anesth Analg 102: 1768-1774.
13. Lemberg KK, Kontinen VK, Siiskonen AO, Viljakka KM, Yli-Kauhaluoma JT, Korpi ER et al (2006a). Antinociception by spinal and systemic oxycodone: why dose the route make a difference? Anesthesiology 105: 801-812.
14. Malmberg A, Basbaum AI (1998). Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates. Pain 76: 215-222.
15. Mayer DJ, Mao J, Holt J, Price DD (1999). Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc Natl Acad USA 96: 7731-7736.
16. Narita M, Funada M, Suzuki T (2001c). Regulations of opioid dependence by opioid receptor types. Pharmacol Ther 89: 1-15.
17. Narita M, Imai S, Ozaki S, Suzuki M, Narita M, Suzuki T (2003). Reduced expression of a novel μ-opioid receptor (MOR) subtype MOR-1B in CXBK mice: implication of MOR-1B in the expression of MOR-mediated responses. Eur J Neuroscience 18: 3193-3198.
18. Narita M, Kishimoto Y, Ise Y, Yajima Y, Misawa K, Suzuki T (2005a). Direct evidence for the involvement of the mesolimbic kappa-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state. Neuropsychopharmacology 30: 111-118.
19. 5] enkephalin. J Neurosci 21: 3715-3720.
20. Narita M, Mizoguchi H, Suzuki T, Narita M, Dun NJ, Imai S et al (2001a). Enhanced mu-opioid responses in the spinal cord of mice lacking protein kinase Cgamma isoform. J Biol Chem 276: 15409-15414.
21. Narita M, Usui A, Narita M, Niikura K, Nozaki H, Khotib J et al (2005b). Protease-activated receptor-1 and platelet-derived growth factor in spinal cord neurons are implicated in neuropathic pain after nerve injury. J Neurosci 25: 10000-10009.
22. Narita M, Yajima Y, Aoki T, Ozaki S, Narita M, Mizoguchi H et al (2000). Up-regulation of the TrkB receptor in mice injured by the partial ligation of the sciatic nerve. Eur J Pharmacol 401: 187-190.
23. Nichols ML, Michael DB, Ossipov MH, Lai J, Porreca F (1995). Regulation of morphine antiallodynic efficacy by cholecystokinin in a model of neuropathic pain in rats. J Pharmacol Exp Ther 275: 1339-1345.
24. Ohsawa M, Narita M, Mizoguchi H, Suzuki T, Tseng LF (2000). Involvement of spinal protein kinase C in thermal hyperalgesia evoked by partial sciatic nerve ligation, but not by inflammation in mice. Eur J Pharmacol 403: 81-85.
25. Ossipov MH, Lopez Y, Nichols ML, Bian D, Porreca F (1995). The loss of antnociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive. Neurosci Lett 199: 87-90.
26. Ozaki S, Narita M, Narita M, Iino M, Sugita J, Matsumura Y et al (2002). Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: implication of the reduction in μ-opioid receptor functions in the ventral tegmental area. J Neurochem 82: 1192-1198.
27. Ozaki S, Narita M, Narita M, Ozaki M, Khotib J, Suzuki T (2004). Role of extracellular signal-regulated kinase in the ventaral tegmental area in the suppression of the morphine-induced rewarding effect in mice with sciatic nerve ligation. J Neurochem 88: 1389-1397.
28. Peckham ME, Tratnor JR (2006). Comparison of the antinociceptive response to morphine and morphine-like compounds in male and female Sprague-dawley rats. J Pharmacol Exp Ther 361: 1195-1201.
29. Paxions G, Franklin KBJ (2001). The Mouse Brain in Stereotaxic Coordinates, 2nd edn. Academic Press: San Diego.
30. Porreca F, Tang QB, Bian D, Riedl M, Elde R, Lai J (1998). Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury. Brain Res 795: 197-203.
31. Ross FB, Smith MT (1997). The intrinsic antinociceptive effects of oxycodone appear to be κ-opioid receptor mediated. Pain 73: 151-157.
32. Satthl C, Christrup LL, Andersen SD, Arendt-Nielsen L, Drewes AM (2006). A comparative study of oxycodone and morphine in a multi-model, tissue-differentiated experimental pain model. Pain 123: 28-36.
33. Sawe J, Kager L, Svensson EJO, Rane A (1985). Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation. Br J Clin Pharmacol 19: 495-501.
34. Seltzer Z, Dubner R, Shi Y (1990). A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 43: 205-218.
35. Siddall PJ, Gray M, Rutkowski S, Cousins MJ (1994). Intrathecal morphine and clonidine in the management of spinal cord injury pain: a case report. Pain 59: 147-148.
36. Silva RM, Rossi GC, Mathis JP, Standifer KM, Pasternak GW, Bodnar RJ (2000). Morphine and morphine-6β-glucuronide-induced feeding are differentially reduced by G-protein a-subunit antisense probes in rats. Brain Res 876: 62-75.
37. Suzuki R, Chapman V, Dickenson AH (1999). The effectiveness of spinal and systemic morphine on rat dorsal horn neuronal responses in the spinal nerve ligation model of neuropathic pain. Pain 80: 215-228.
38. Suzuki T, Kishimoto Y, Misawa M (1996). Formaline- and carrageenan-induced inflammation attenuates place preferences produced by morphine, methamphetamine and cocaine. Life Sci 59: 1667-1674.
39. Suzuki T, Kishimoto Y, Misawa M, Nagase H, Takeda F (1999). Role of the kappa-opioid system in the attenuation of the morphine-induced place preference under chronic pain. Life Sci 64: PL1-PL7.
40. Suzuki T, Kishimoto Y, Ozaki S, Narita M (2001). Mechanism of opioid dependence and interaction between opioid receptors. Eur J Pain 5(Suppl A): 63-65.
41. Tunblad K, Jonsson EN, Hammarlund-Udenaes M (2003). Morphine blood-brain barrier transport is influenced by probenecid co-administration. Pharm Res 20: 618-623.
42. Vaccarino AL, Marek P, Kest B, Ben-Eliyasu S, Couret Jr LC, Kao B et al (1993). Morphine failes to produce tolerance when administered in the presence of formalin pain in rats. Brain Res 627: 287-290.
43. Watson CPN, Babul N (1998). Efficacy of oxycodone in neuropathic pain. A randomized trial in postherpetic neuralgia. Neurology 50: 1837-1841.
44. Zhao C, Tall JM, Meyer RA, Raja SN (2004). Antiallodynic effects of systemic and intrathecal morphine in the spared nerve injury model of neuropathic pain in rats. Anesthesiology 100: 905-911.